Lillian Siu, AACR President and Director of the Phase I Clinical Trials Program at at Princess Margaret Cancer Centre, shared AACR‘s, post on X, adding:
“Brain cancers are among the most lethal and biologically complex forms of the disease. We are grateful to the AACR Brain 2026 co-chairs for convening leading experts from academia, industry, and the clinic to catalyze new scientific partnerships and move the field forward.”
Quoting AACR‘s post:
“As we adjourn the AACR Special Conference on Brain Cancer, we thank AACR Brain 2026 co-chairs Stephen Bagley, Michelle Monje, and Mario Suva, invited speakers, and abstract presenters for their contributions to this outstanding program.”
Other articles featuring Lillian Siu and AACR on OncoDaily.